Data base for:

  • Conferences
  • Research funding opportunities
  • Competitions / Awards

Register for free and add any data by yourself!

Filter conferences

 
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
      
 
      
      
 
      
 
      
      
      
      
      
      
      
      
      
      
Antibody Engineering and Therapeutics ASIA

Antibody Engineering and Therapeutics ASIA

THE ONLY EVENT IN ASIA PROVIDING THE LATEST SCIENCE, TECHNOLOGY AND PARTNERS TO ACCELERATE ANTIBODY and PROTEIN THERAPIES, ADCS, BISPECIFICS AND IMMUNO-ONCOLOGY.

Categories

Date of beginning

Monday, 24 February 2020

Duration

3 days

City

Kyoto

Country

Japan

Contact

Frances Pratt

E-Mail

This email address is being protected from spambots. You need JavaScript enabled to view it.

Memo

World-renowned scientists sharing the latest technologies, RandD and clinical data to fast-track your next-generation therapeutics towards commercial success. 7 Conference Session Themes:- Novel Engineering and Discovery Strategies- ADCs/Antibody-Drug Conjugates- Bispecific Antibodies and Multi-Functional Biologics- Immuno-Oncology- Preclinical and Clinical Case Studies- Delivery Strategies and Crossing/Penetrating Biological Barriers- Engineering Strategies for TCR and CAR T Cell Therapies Prices:Industry - Conference Only: USD 1699.0,Academic - Conference Only: USD 699.0 Speakers: Sally Ward, PhD, Professor, Texas AandM University Health Science Center and University of Southampton, United Kingdom, Shohei Koide, PhD, Professor of Biologics Design, Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, USA, Paul W.H.I. Parren, PhD, EVP and Head of RandD, Lava Therapeutics and Professor, Leiden University Medical Center, The Netherlands, Tomoyuki Igawa, PhD, CEO and Research Head, Global Biologics Leader, Chugai Pharmabody Research Pte. Ltd., Singapore, Robert Mabrey, PhD, Head of Global Biologics, Takeda, USA Time: 09:00 - 17:00